| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |